Cytogenetic abnormalities in lung cancer

Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.

Acta haematologica·2001

Hematopoietic growth factors in cancer chemotherapy.

Cancer chemotherapy and biological response modifiers·2000

Clinical benefits of improving host defences with rHuG-CSF.

Ciba Foundation symposium·1997

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Annals of internal medicine·1994

Protection from lethal irradiation by the combination of stem cell factor and tempol.

Radiation research·1994

Stem cell factor is a potent synergistic factor in hematopoiesis.

Oncology·1994

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026

Clinical Research on Microecological Landscape for Infection Risk Stratification in Newly Diagnosed Patients with Hematological Conditions.

Infectious diseases and therapy·2026

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Hepatology (Baltimore, Md.)·2026

Resection of hemorrhagic intracranial testicular choriocarcinoma metastasis with a novel camera-suction device: A surgical case report.

Surgical neurology international·2026

The profile of pleural effusions in oncological patients referred to the cardiothoracic surgery department in a tertiary hospital in Pretoria, South Africa: A retrospective study.

African journal of thoracic and critical care medicine·2026

Recurrent Desmoid-Type Fibromatosis of the Breast in a Young Woman With a Monoallelic MUTYH Germline Variant.

Cureus·2026

Macrophage NPM1 drives anti-tumor immunity via the STAT3-CCRL2 axis.

Frontiers in immunology·2026

Related Experiment Videos

Cytogenetic abnormalities in lung cancer

Related Concept Videos

Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.

Hematopoietic growth factors in cancer chemotherapy.

Clinical benefits of improving host defences with rHuG-CSF.

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Protection from lethal irradiation by the combination of stem cell factor and tempol.

Stem cell factor is a potent synergistic factor in hematopoiesis.

Clinical Trials and Translational Advances in Metabolic Targeting.

Tools and Technologies for Studying Cancer Metabolism.

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Biomarkers of Cancer Metabolism and Therapeutic Response.

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Metabolic Reprogramming in Cancer Stem Cells.

Clinical Research on Microecological Landscape for Infection Risk Stratification in Newly Diagnosed Patients with Hematological Conditions.

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Resection of hemorrhagic intracranial testicular choriocarcinoma metastasis with a novel camera-suction device: A surgical case report.

The profile of pleural effusions in oncological patients referred to the cardiothoracic surgery department in a tertiary hospital in Pretoria, South Africa: A retrospective study.

Recurrent Desmoid-Type Fibromatosis of the Breast in a Young Woman With a Monoallelic MUTYH Germline Variant.

Macrophage NPM1 drives anti-tumor immunity via the STAT3-CCRL2 axis.

Related Experiment Videos

Cytogenetic abnormalities in lung cancer

Related Concept Videos

Related Articles